PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Word 1
Word 1 Count
CAT1
CAT2
Word 2
Word 2 Count
Co-occurrence
Occurence-Centile
Correlation
Overlap-Metric
G-Metric
Amitiza (Lubiprostone)- FDA 19 Drug Drug Alosetron Hydrochloride (Lotronex)- FDA 27 2 0.09 -0.91 0.11 0.86
Doxacurium Chloride 19 Drug Disease Hypotension 42,123 1 0.00 -0.97 0.05 0.59
Doxacurium Chloride 19 Drug Disease Muscle Relaxation 4,706 2 0.01 -0.95 0.11 0.67
Mu-Type Opioid Receptor 19 Target Disease Pain 409,851 1 0.00 -0.97 0.05 0.54
Amitiza (Lubiprostone)- FDA 19 Drug Disease Pain 409,851 5 0.00 -0.86 0.26 0.58
ALK Phos 19 Target Disease Liver Disease 49,817 1 0.00 -0.97 0.05 0.59
ALK Phos 19 Target Disease Inflammation 252,734 1 0.00 -0.97 0.05 0.55
ALK Phos 19 Target Disease Skin Rash 3,684 1 0.00 -0.97 0.05 0.65
ALK Phos 19 Target Disease Breast Cancer 173,695 1 0.00 -0.97 0.05 0.56
ALK Phos 19 Target Disease Pain 409,851 1 0.00 -0.97 0.05 0.54
ALK Phos 19 Target Disease Hepatitis 163,842 1 0.00 -0.97 0.05 0.56
Amitiza (Lubiprostone)- FDA 19 Drug Disease Irritable Bowel Syndrome 8,230 14 0.04 -0.51 0.74 0.71
Amitiza (Lubiprostone)- FDA 19 Drug Disease Ileus 9,091 1 0.00 -0.97 0.05 0.63
Kaad-Cyclopamine 19 Drug Target ERK1 18,374 1 0.00 -0.97 0.05 0.61
Aralen (Chloroquine)- FDA 19 Drug Drug Acitretin (Soriatane)- FDA 13 2 0.13 -0.87 0.15 0.88
Dropropizine 19 Drug Disease Sedation 27,984 1 0.00 -0.97 0.05 0.60
Eotaxin-2/CCL24 19 Target Disease Inflammatory Bowel Diseases 4,684 1 0.00 -0.97 0.05 0.65
AMAC-1 19 Target Target Eotaxin 2,457 1 0.00 -0.97 0.05 0.66
AMAC-1 19 Target Target DC-CK1 22 4 0.20 -0.80 0.21 0.90
AMAC-1 19 Target Disease Infection 766,637 1 0.00 -0.97 0.05 0.53
AMAC-1 19 Target Target CD14 9,941 1 0.00 -0.97 0.05 0.63
Eotaxin-2/CCL24 19 Target Target CCL1 220 1 0.02 -0.97 0.05 0.74
Eotaxin-2/CCL24 19 Target Disease Inflammation 252,734 5 0.00 -0.86 0.26 0.59
Eotaxin-2/CCL24 19 Target Target CCL8 197 1 0.02 -0.97 0.05 0.75
AMAC-1 19 Target Target CCL4 5,638 1 0.00 -0.97 0.05 0.64
Eotaxin-2/CCL24 19 Target Disease Rheumatoid Arthritis 78,952 1 0.00 -0.97 0.05 0.58
AMAC-1 19 Target Target CCL18 256 4 0.06 -0.88 0.21 0.79
AMAC-1 19 Target Disease Cancer 1,053,491 1 0.00 -0.97 0.05 0.53
AMAC-1 19 Target Disease Osteoarthritis 36,287 1 0.00 -0.97 0.05 0.60
Kaad-Cyclopamine 19 Drug Disease Glioblastoma 17,933 2 0.00 -0.95 0.11 0.63
Kaad-Cyclopamine 19 Drug Target Activin A 2,048 1 0.01 -0.97 0.05 0.67
Eotaxin-2/CCL24 19 Target Target Collagen 138,882 1 0.00 -0.97 0.05 0.57
Eotaxin-2/CCL24 19 Target Target CCL3 1,427 1 0.01 -0.97 0.05 0.68
Eotaxin-2/CCL24 19 Target Disease Asthma 109,610 4 0.00 -0.89 0.21 0.60
AMAC-1 19 Target Disease Arthritis 128,324 1 0.00 -0.97 0.05 0.57
Kaad-Cyclopamine 19 Drug Disease Carcinoma 433,099 7 0.00 -0.79 0.37 0.58
Aralen (Chloroquine)- FDA 19 Drug Drug Atovaquone (Mepron)- FDA 11 3 0.21 -0.78 0.27 0.90
Kaad-Cyclopamine 19 Drug Target EGF 27,487 1 0.00 -0.97 0.05 0.60
Kaad-Cyclopamine 19 Drug Disease Breast Cancer 173,695 2 0.00 -0.95 0.11 0.58
Kaad-Cyclopamine 19 Drug Disease Lung Cancer 91,416 1 0.00 -0.97 0.05 0.58
Kaad-Cyclopamine 19 Drug Disease Prostate Cancer 71,064 1 0.00 -0.97 0.05 0.58
Kaad-Cyclopamine 19 Drug Disease Ovarian Cancer 33,996 1 0.00 -0.97 0.05 0.60
Doxacurium Chloride 19 Drug Drug Doxacurium 85 19 0.47 -0.20 1.00 0.91
Aralen (Chloroquine)- FDA 19 Drug Disease Rheumatoid Arthritis 78,952 1 0.00 -0.97 0.05 0.58
Kaad-Cyclopamine 19 Drug Disease Cancer 1,053,491 13 0.00 -0.56 0.68 0.58
Aralen (Chloroquine)- FDA 19 Drug Disease Malaria 56,215 7 0.01 -0.79 0.37 0.63
Aralen (Chloroquine)- FDA 19 Drug Disease Pain 409,851 1 0.00 -0.97 0.05 0.54
Aralen (Chloroquine)- FDA 19 Drug Disease Breast Cancer 173,695 1 0.00 -0.97 0.05 0.56
Aralen (Chloroquine)- FDA 19 Drug Drug Doxycycline 9,324 2 0.00 -0.95 0.11 0.65
464.1 19 Target Disease Cholesterol 182,390 1 0.00 -0.97 0.05 0.56